Tissue plasminogen activator (rt-PA) has been the only approved specific drug for acute ischemic stroke (AIS) for two decades until 2015 (2), when the European and US guidelines also recommended mechanical thrombectomy as a first-line treatment in AIS due to a large vessel occlusion (3). The gene discussed is PLAT; the disease is androgen insensitivity syndrome.